InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
· Virtual R&D event to be held on June 5, 2024 from 12:00 to 2:00 PM EDT – highlighting company plans for INF904 and the..
Committee for Medicinal Products for Human Use
News and Video Search Results
News coverage
-
A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
Accesswire
-
Bavarian Nordic Announces Interim Results for the First Three Months of 2024
GlobeNewswire
-
Pharming Group reports first quarter 2024 financial results and provides business update
GlobeNewswire
-
Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates
GlobeNewswire
0 shares
1 views
You might like
Committee for Medicinal Products for Human Use media coverage
A Novel Broad-Spectrum Antiviral with Activity Against Influenza A
*NV-387 Possesses Strong Anti-Influenza-A Virus Activity, and May Have Activity Against H5N1 Bird Flu Virus, Says..
Accesswire
Worldwide: Biosimilar Approval Updates In Europe And China - Goodwin Procter LLP
On April 25, 2024, the Committee for Medicinal Products for Human Use ("CHMP") adopted a positive opinion, recommending the..
Mondaq